Position: Full Professorship (W2/W3) for Signaling-Based Precision Oncology

Code number: 2021-0137

Charité – Universitätsmedizin Berlin is one of the largest university hospitals in Europe, where physicians and researchers provide clinical care, research and teaching of the highest international standard. The Charité represents a single medical faculty that serves both the Humboldt-Universität zu Berlin and the Freie Universität Berlin, and is esteemed worldwide for its excellence in teaching and training. The Charité extends over four campuses, and has close to 100 different departments and institutes, which make up a total of 17 different CharitéCenters. The Charité has been awarded the certificates ‘family-friendly employer’ (audit berufundfamilie®) and ‘family-friendly university’ (audit familiengerechte hochschule®) and is a member of the “Dual Career Network Berlin” (www.dualcareer-berlin.de).

The German Cancer Consortium (DKTK) is a joint initiative of the German Federal Ministry of Education and Research (BMBF), the participating states and the DKFZ. The alliance between the DKFZ as the core center and the university partner sites in Berlin, Dresden, Essen / Düsseldorf, Frankfurt / Mainz, Freiburg, München and Tübingen establishes joint translational cancer research units. The DKTK promotes interdisciplinary research approaches and innovative clinical studies, which will contribute to improved prevention, diagnosis and faster implementation of personalized therapies for cancer patients. DKFZ has been awarded the certificate “Audit Career and Family” and offers a large spectrum of equal opportunities (https://www.dkfz.de/en/gleichstellungsbeauftragte/index.html).

 

The Charité – Universitätsmedizin Berlin and the German Cancer Research Center (DKFZ) jointly invite applications for the following position commencing as soon as possible

Full Professorship (W2/W3) for Signaling-Based Precision Oncology

Salary Group W2/W3 BBesG ÜfBE – tenured

(Reference Number Charité: Prof. 586/2021, Reference Number DKFZ: 2021-0137)

 

Classification in grade W2 or W3 depends on the personal qualifications and personal experience of the future position holder.

The position is to be filled at the partner site Berlin of the German Cancer Consortium (DKTK).  According to the “Jülicher Modell” the successful candidate will be appointed as a full professor of the Charité –Universitätsmedizin and will be granted leave of absence in order to be employed at the DKFZ. Provided that all legal requirements are met, the candidate will get a civil servant status for life. The translational oncology group will be located at the Charité and will be an integral part of the DKTK operations at this partner site.

We invite applications for a highly motivated candidate with an excellent scientific track record to build up a multidisciplinary research team for translation of new developments in cancer research into clinical applications as defined by DKTK in its program (http://www.dktk.org). The successful candidate should have an internationally recognized record of accomplishment, preferably in the field of cancer-oriented functional omics analyses, a vision for an innovative research program and a strong motivation to interact with research groups in basic, translational and clinical cancer research. Important prerequisites are cutting-edge contributions to cancer research enabling efficient target identification/ validation and drug evaluation as well as an enhanced understanding of oncogenic signal transduction, complemented by expertise in the interpretation of complex cancer-related datasets.

Specific research fields to be strengthened in the near future at the DKTK partner site Berlin include:

  • genetic screening technologies in pre-clinical models and patient biomaterial
  • metabolomics/cancer metabolism
  • characterization of tumor heterogeneity
  • characterization of the tumor microenvironment
  • DNA damage response signaling/DNA replication stress

The successful candidate should hold expertise in one of the above areas. Additional research interfaces with immunotherapy applications are considered to be a particularly valuable asset. Applicants should have an excellent publication record, a successful history of funding acquisition and sound experience as a group leader. 

The future position holder is expected to fulfil the following responsibilities and criteria:

  • An excellent publication record 
  • Proof of outstanding research achievements and successful attainment of competitive third-party research funding
  • Established experience as a group leader as well as strong leadership and coordination skills
  • Integration into existing coordinated research collaborations and graduate schools of the Charité (www.charite.de) and the DKFZ (www.dkfz.de), the DKTK (www.dktk.org) and co-operations with the scientific and clinical community of the Berlin Institute of Health (BIH), and other institutions in Berlin and Brandenburg
  • Experience and commitment in teaching, excellent didactic skills and willingness to actively participate in teaching activities at Charité and DKFZ/DKTK, supervision of master and doctoral students, and participation in academic self-administration
  • Consideration of gender and diversity both in terms of research content and personnel

Qualifications: According to the higher education act of Berlin for hiring professors (§ 100 BerlHG), the academic prerequisites for this position include either a professorship or junior professorship, postdoctoral thesis (habilitation), or equivalent scientific achievement including qualified teaching experience or a similar qualification. Furthermore, a completed university degree as well as doctorate (Ph.D. and/or M.D.) in medicine or natural science with significant post-doctoral experience is required.

The Charité and the DKTK are committed to increasing the proportion of women among the scientific staff, we therefore strongly encourage women to apply. In the event of equally qualified applicants, women will be given preference over men (within the scope of what is permitted by law). Applicants with disabilities will be given preference over equally qualified non-disabled applicants. We value diversity and therefore welcome all applications – regardless of gender, nationality, social background, religion or age.

Written applications according to the format specified on https://career.charite.de/am/calls/application_notes.pdf should be submitted by June 28, 2021 at https://career.charite.de (Reference Number Charité: Prof. 586/2021)

and to

Prof. Dr. Michael Baumann, Chairman and Scientific Director, German Cancer Research Center (DKFZ), Im Neuenheimer Feld 280, 69120 Heidelberg, Germany via the DKFZ online application portal (http://www.dkfz.de/jobs; Reference Number DKFZ: 2021-0137).

Inquiries about the professorship (research and teaching aspect) should be addressed to Prof. Dr. Angelika Eggert, Spokesperson of the DKTK partner site Berlin, angelika.eggert@charite.de

Application Deadline: 28.06.2021


The DKFZ is committed to increase the proportion of women in all areas and positions in which women are underrepresented. Qualified female applicants are therefore particularly encouraged to apply.

Among candidates of equal aptitude and qualifications, a person with disabilities will be given preference.                    

We ask for your understanding that we cannot return application documents that are sent to us by post (Deutsches Krebsforschungszentrum, Personalabteilung, Im Neuenheimer Feld 280, 69120 Heidelberg).